Chaoju Eye Care Holdings Limited filed a Next Day Disclosure Return with the Hong Kong Stock Exchange on 25 June 2026, confirming the latest movement in its share capital and the progress of its ongoing buy-back programme.

Key takeaways

1. Share capital unchanged • Issued ordinary shares remained at 705.18 million as of both 23 June and 25 June 2026. • No treasury shares were outstanding.

2. Latest on-market repurchase • Date: 25 June 2026 • Volume: 58,000 shares (to be cancelled). • Price range: HKD 2.41 – HKD 2.45 per share. • Total consideration: HKD 0.14 million.

3. Cumulative buy-backs under 2026 mandate • Mandate granted on 12 May 2026 permits repurchase of up to 70.52 million shares. • From 12 May through 25 June 2026, the company has repurchased 837,000 shares, equivalent to 0.12 % of the issued share count on the mandate date. • Including pre-mandate acquisitions (since 2 April 2026), shares bought back but not yet cancelled total 1.22 million.

4. Post-repurchase restrictions • In line with HKEX rules, Chaoju Eye Care is subject to a moratorium on issuing new shares until 25 July 2026.

All repurchases were executed on the Hong Kong Stock Exchange and will be cancelled upon settlement, aligning with board authorization and regulatory requirements.